Celldex Therapeutics reported $407K in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US USD 14.81B 229M
Agenus AGEN:US USD 22.77M 1.85M
Amgen AMGN:US USD 6.65B 58M
Biocept BIOC:US USD 5.59M 5.02M
Bristol Myers Squibb BMY:US USD 11.22B 669M
Celldex Therapeutics CLDX:US USD 407K 244K
Cytrx CYTR:US USD 0 0
Glaxosmithkline GSK:US GBP 7.83B 900M
Immunogen IMGN:US USD 15.38M 1.21M
Nektar Therapeutics NKTR:US USD 23.62M 2.04M
Newlink Genetics NLNK:US USD 497K 94K
Northwest Biotherapeutics NWBO:US USD 206K 271K
Pfizer PFE:US USD 22.64B 5.1B
Rigel Pharmaceuticals RIGL:US USD 22.41M 7.41M
Roche Holding ROG:VX CHF 32.3B 207M
Seattle Genetics SGEN:US USD 510.3M 12.8M